Apollo Medical Cannabis Research

Apollo Applied Research (Apollo Cannabis Clinics) has been conducting medical cannabis research since 2013. With their published peer-reviewed chronic pain research study, Apollo’s patients have validated that medical cannabis can help manage chronic pain, can improve mental health, and may assist with reducing opioids in pain management. 

Apollo’s patients reported a 43% reduction in the interference of pain with their daily activities and a 37% reduction in the severity of their pain

Those who disclosed opioid medication use at baseline reported a clinically significant 95% reduction in oral morphine equivalent doses, as well as a 30% reduction in their pain and 40% reduction in the severity of their pain. 

Three months after initiating the medical cannabis treatment, patients reported significant improvements in physical and mental health with decreases in headaches, fatigue, anxiety, and nausea.

The findings of this study add to the cumulative evidence in support of plant-based medical cannabis as a safe and effective treatment option and potential opioid medication substitute or augmentation therapy for the management of symptoms and quality of life in chronic pain patients.

See the published abstract of the study here.

“One of the most advanced tests for cannabis impairment is being developed in Toronto”

 Apollo Applied Research (Apollo Cannabis Clinics) is excited to announce the completion of phase one of a new research study that is intended to help improve police officers’ screening methods of cannabis related impairment at roadside. Apollo conducted the study with the University Health Network, funded by the Provincial Government to detect roadside safety using a tablet-based screening tool.
Read more here about the technology, research, and collaborations used to create safer roads for everyone.